These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29703774)

  • 1. [
    Passamonti L; Rodríguez PV; Hong YT; Allinson KSJ; Bevan-Jones WR; Williamson D; Jones PS; Arnold R; Borchert RJ; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Neurology; 2018 May; 90(22):e1989-e1996. PubMed ID: 29703774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation predicts disease progression in progressive supranuclear palsy.
    Malpetti M; Passamonti L; Jones PS; Street D; Rittman T; Fryer TD; Hong YT; Vàsquez Rodriguez P; Bevan-Jones WR; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):769-775. PubMed ID: 33731439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.
    Bevan-Jones WR; Surendranathan A; Passamonti L; Vázquez Rodríguez P; Arnold R; Mak E; Su L; Coles JP; Fryer TD; Hong YT; Williams G; Aigbirhio F; Rowe JB; O'Brien JT
    BMJ Open; 2017 Jan; 7(1):e013187. PubMed ID: 28064175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy.
    Malpetti M; Passamonti L; Rittman T; Jones PS; Vázquez Rodríguez P; Bevan-Jones WR; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Ann Neurol; 2020 Dec; 88(6):1194-1204. PubMed ID: 32951237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.
    Gerhard A; Trender-Gerhard I; Turkheimer F; Quinn NP; Bhatia KP; Brooks DJ
    Mov Disord; 2006 Jan; 21(1):89-93. PubMed ID: 16108021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding of a tau imaging probe, [
    Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
    Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance.
    Passamonti L; Tsvetanov KA; Jones PS; Bevan-Jones WR; Arnold R; Borchert RJ; Mak E; Su L; O'Brien JT; Rowe JB
    J Neurosci; 2019 Sep; 39(36):7218-7226. PubMed ID: 31320450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease.
    Parbo P; Ismail R; Hansen KV; Amidi A; Mårup FH; Gottrup H; Brændgaard H; Eriksson BO; Eskildsen SF; Lund TE; Tietze A; Edison P; Pavese N; Stokholm MG; Borghammer P; Hinz R; Aanerud J; Brooks DJ
    Brain; 2017 Jul; 140(7):2002-2011. PubMed ID: 28575151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo retention of
    Smith R; Schöll M; Widner H; van Westen D; Svenningsson P; Hägerström D; Ohlsson T; Jögi J; Nilsson C; Hansson O
    Neurology; 2017 Aug; 89(8):845-853. PubMed ID: 28754841
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins.
    Perez-Soriano A; Arena JE; Dinelle K; Miao Q; McKenzie J; Neilson N; Puschmann A; Schaffer P; Shinotoh H; Smith-Forrester J; Shahinfard E; Vafai N; Wile D; Wszolek Z; Higuchi M; Sossi V; Stoessl AJ
    Mov Disord; 2017 Jul; 32(7):1016-1024. PubMed ID: 28568506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
    Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
    Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy combined with Alzheimer's disease: a clinicopathological study of two autopsy cases.
    Sakamoto R; Tsuchiya K; Yoshida R; Itoh Y; Furuta N; Kosuga A; Sugai Y; Mimura M
    Neuropathology; 2009 Jun; 29(3):219-29. PubMed ID: 18992014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.
    Schröter N; Blazhenets G; Frings L; Barkhausen C; Jost WH; Weiller C; Rijntjes M; Meyer PT
    Clin Nucl Med; 2020 Apr; 45(4):283-287. PubMed ID: 32108694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.